From the CEO


Based on our Raison D'être to “Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products,” Astellas has strived to deliver innovative medical solutions that meet patients’ needs. We are committed to achieving our VISION of being “on the forefront of healthcare change, turning innovative science into VALUE for patients.”

Continuous innovation is our lifeline. We have adopted a Focus Area Approach to our research and development strategy, and are working to create innovative products that respond flexibly to rapid advances in science and the accompanying changes in how we perceive and treat diseases. We are also committed to developing products that not only improve a patient’s symptoms but can significantly transform the underlying causes of disease, such as cell and gene therapies. In the Rx+® business, we are also striving to integrate innovative medical technology with cutting-edge technology in various other fields, leveraging the strength we have cultivated through our prescription medicine (Rx) business. We aim to deliver VALUE for patients in various ways across the whole patient journey (overall medical care, including preventive, diagnostic, therapeutic and prognostic care).

We must take further steps to foster a corporate culture in which:

  • We learn from our mistakes and take intelligent risks
  • Every employee thinks for themselves and demonstrates leadership
  • We strive to excel as One Astellas.

We also want to be results-oriented, which is on top of setting ambitious goals and doing our best to achieve them. In the Corporate Strategic Plan 2021, we have set three types of goals: Strategic, Organizational Health, and Performance Goals, and we are working to achieve steady growth and deliver results by FY2025.

We cannot do business alone. We will continue to listen to the voice of patients and their families, the opinions of all stakeholders, including healthcare professionals, business partners, and investors and shareholders, and reflect them in our business. In this way, Astellas will continue to turn innovative science into VALUE for patients.

Naoki Okamura
Representative Director,
President and Chief Executive Officer (CEO)